News from OrbusNeich Medical, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

11 Jan, 2017, 05:00 ET OrbusNeich Expands Portfolio with a Next Generation Coronary Scoring Balloon

Launch of Scoreflex™ NC responds to cardiologists' need for a non-compliant scoring balloon in more resistant lesions OrbusNeich, a global...


11 Jan, 2017, 05:00 ET OrbusNeich amplía su cartera con un balón de scoring coronario de nueva generación

El lanzamiento de Scoreflex™ NC responde a la necesidad de los cardiólogos de un balón scoring no distensible para lesiones más...


11 Jan, 2017, 05:00 ET OrbusNeich erweitert sein Portfolio um einen neuartigen Non-Compliant Koronar-Scoring-Ballonkatheter

Mit der Einführung des neuen Scoreflex™ NC reagiert OrbusNeich auf den gestiegenen Bedarf interventioneller Kardiologen an einem Non-Compliant...


11 Jan, 2017, 05:00 ET OrbusNeich élargit sa gamme avec un ballon de scoring coronaire de nouvelle génération

Le lancement de Scoreflex™ NC répond au besoin des cardiologues avec un ballon de scoring non compliant pour les lésions les plus résistantes...


21 Nov, 2016, 05:30 ET OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing

COMBO Plus: A combination of traditional drug-eluting stent (DES) components with the addition of a unique biological therapy and enhanced...


21 Nov, 2016, 05:30 ET OrbusNeich presenta el nuevo COMBO Plus Dual Therapy Stent

-OrbusNeich presenta el COMBO Plus Dual Therapy Stent de nueva generación para la rendotelizacion activa COMBO Plus: Una combinación de los...


24 May, 2016, 05:29 ET OrbusNeich expande su cartera para tratar la enfermedad arterial periférica

OrbusNeich, una compañía global especializada en el suministro de soluciones vasculares que cambian las vidas, ha expandido su cartera...


24 May, 2016, 05:20 ET OrbusNeich erweitert sein Portfolio um die Behandlung der peripheren arteriellen Verschlusskrankheit

Die Innovatoren des COMBO™ Stents präsentieren Katheter für die unteren Extremitäten und AV-Fisteln. OrbusNeich, ein...


24 May, 2016, 05:15 ET OrbusNeich élargit son portefeuille pour traiter la maladie artérielle périphérique

Les créateurs de COMBO™, la première endoprothèse à double thérapie au monde, présentent des cathéters...


24 May, 2016, 05:10 ET OrbusNeich expande su cartera para tratar la enfermedad arterial periférica

Los innovadores de COMBO[TM], el primer stent de doble terapia del mundo, introduce catéteres para la intervención de extremidades...


24 May, 2016, 05:06 ET OrbusNeich Expands Portfolio to Treat Peripheral Disease

The innovator of COMBO™,the world's first dual therapy stent, introduces catheters for lower limb and AV fistula...


19 Oct, 2015, 06:39 ET One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

OrbusNeich, a global company specializing in the provision of life-changing vascular solutions, has announced today the presentation of the...


18 May, 2015, 17:28 ET OrbusNeich kündigt Einleitung von HARMONEE-Stent-Studie in den USA an

Registrierungsstudie wird 572 Patienten an bis zu 50 Studienstandorten in Japan und den USA einbeziehen OrbusNeich, ein globales Unternehmen, das...


18 May, 2015, 13:07 ET OrbusNeich anuncia el inicio del estudio de stent HARMONEE en EE. UU.

El estudio de registro reclutará a 572 pacientes en 50 localizaciones de estudio en Japón y EE. UU.   OrbusNeich, una...


18 Sep, 2014, 04:00 ET Latest Data Shows OrbusNeich's COMBO™ Dual Therapy Stent has Excellent Healing Benefits

The world's first and only dual therapy stent  Prof. Stephen W.L. Lee presented two-year optical coherence tomography (OCT) findings and...


16 Jul, 2014, 05:00 ET Eerste patiëntinschrijving in MASCOT-register vormt belangrijke mijlpaal voor de COMBO™ Dual Therapy Stent en klinisch programma van OrbusNeich

Onderzoek onder 2500 patiënten en in 50 centra is het grootste post-marketingregister over veiligheid en effectiviteit...


16 Jul, 2014, 05:00 ET Erste Aufnahme eines Patienten in das MASCOT-Register stellt einen großen Meilenstein für das klinische COMBO™ Dual Therapy Stent Studien Programm von OrbusNeich dar

Die Studie über die Sicherheit und Wirksamkeit des COMBO-Stents    an 2.500 Patienten in 50 Zentren ist...


23 May, 2014, 10:18 ET OrbusNeich maakt langetermijngegevens bekend over 's werelds eerste en enige dubbele therapie-stent

 COMBO™ dubbele therapie-stent (Dual Therapy Stent) blijkt snelle endothelialisatie actief te bevorderen en op lange termijn tot echte...


23 May, 2014, 07:07 ET OrbusNeich gibt langfristige Daten für den ersten und einzigen Dual Therapy Stent der Welt frei

Es hat sich gezeigt, dass der COMBO™ Dual Therapy Stent aktiv eine schnelle Endothelialisierung (Neubildung der Gefäßinnenwand)...


23 May, 2014, 03:00 ET OrbusNeich Releases Long-term Data for World's First and Only Dual Therapy Stent

OrbusNeich today announced long-term results from its REMEDEE Trial. In addition to showing that the COMBO™ Dual Therapy Stent shows no late...


28 Mar, 2014, 09:00 ET Patient Enrollment Completed in Multicenter European REMEDEE Registry of OrbusNeich's COMBO Dual Therapy Stent™

OrbusNeich today announced the completion of enrollment in the prospective, multicenter, all-comers REMEDEE Registry (Multicenter, Prospective,...


29 Oct, 2013, 17:58 ET OrbusNeich's COMBO™ Dual Therapy Stent Shows Excellent Early Healing and Durable Outcomes out to 24 Months

 OrbusNeich today announced that new clinical data presented at TCT 2013 show durable outcomes as well as excellent early healing and optimal...


22 Oct, 2013, 10:00 ET Clinical Data for OrbusNeich's COMBO™ Dual Therapy Stent to Be Presented at TCT 2013

OrbusNeich today announced that clinical data for the COMBO Dual Therapy Stent will be presented at Transcatheter Cardiovascular Therapeutics (TCT)...


06 Aug, 2013, 09:30 ET First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich's COMBO Dual Therapy Stent™ in Routine Practice

 Patient enrollment has been initiated in a post-market registry for the COMBO Dual Therapy Stent to evaluate its long-term safety and...


27 May, 2013, 03:00 ET OrbusNeich Launches World's First Dual Therapy Stent That Addresses Challenges of Delayed Coronary Artery Healing Associated with Monotherapy Drug Eluting Stents

OrbusNeich today launched the world's first dual therapy stent – the COMBO Dual Therapy Stent – to address the challenges of delayed...